REVVITY, INC Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
REVVITY, INC (RVTY) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $3.05 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-24
- REVVITY, INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2013-03-31 was $9.40M.
- REVVITY, INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $3.05M, a 57.99% decline from fiscal 2024.
- REVVITY, INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $7.25M, a 33.05% decline from fiscal 2023.
- REVVITY, INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $10.83M, a 25.57% increase from fiscal 2023.
- REVVITY, INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $8.63M, a 1431.97% increase from fiscal 2022.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|---|
| 2025-12-28 | $3.05M 10-K · filed 2026-02-24 | |
| 2024-12-29 | $7.25M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $10.83M 10-K · filed 2026-02-24 | |
| 2023-01-01 | $8.63M 10-K · filed 2025-02-25 | |
| 2022-01-02 | $563.00K 10-K · filed 2024-02-27 | |
| 2021-01-03 | $0.00 10-K · filed 2023-03-01 | |
| 2019-12-29 | $0.00 10-K · filed 2022-03-03 | |
| 2018-12-30 | $181.00K 10-K · filed 2021-03-02 | |
| 2017-12-31 | $1.37M 10-K · filed 2020-02-25 | |
| 2017-01-01 | $4.11M 10-K · filed 2019-02-26 | |
| 2016-01-03 | $1.08M 10-K · filed 2018-02-27 | |
| 2014-12-28 | $4.13M 10-K · filed 2017-02-28 | |
| 2013-12-29 | $6.50M 10-K · filed 2016-03-01 | |
| 2013-03-31 | $9.40M 10-Q · filed 2014-11-04 | |
| 2012-12-30 | $595.00K 10-K · filed 2015-02-24 | |
| 2012-01-01 | $2.22M 10-K · filed 2014-02-25 | |
| 2011-01-02 | $2.05M 10-K · filed 2013-02-26 | |
| 2010-01-03 | $2.09M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |